Literature DB >> 20053135

Lack of demonstrable memory T cell responses in humans who have spontaneously recovered from leptospirosis in the Peruvian Amazon.

Iskra Tuero1, Joseph M Vinetz, Gary R Klimpel.   

Abstract

BACKGROUND. We tested the hypothesis that patients who have recovered from leptospirosis have peripheral blood memory T cells that are specific for Leptospira or Leptospira protein antigens. METHODS. Peripheral blood mononuclear cells (PBMCs) were obtained from patients who had recovered from leptospirosis, as well as from control individuals. PBMCs were assessed for in vitro proliferation, phenotyping, and cytokine production after stimulation with different strains of Leptospira, recombinant LipL32, or overlapping synthetic peptides of different outer membrane proteins. RESULTS. PBMCs from both control subjects and patients produced significant proliferative responses to all Leptospira strains. Proliferation from control PBMCs was significantly greater than responses produced by patient PBMCs. Select strains of Leptospira expanded both T cell receptor (TCR) alphabeta and TCRgammadelta T cells in both control subject and patient PBMCs. Patient and control subject PBMCs produced equivalent levels of tumor necrosis factor alpha and interferon gamma, but patient PBMCs produced significantly less interleukin 10 than did control subject PBMCs after stimulation by different strains of Leptospira. PBMCs from patients failed to respond to recombinant LipL32 or to any of the Leptospira peptides. CONCLUSION. Leptospira induced significant proliferative responses, TCRgammadelta T cell expansion, and cytokine production in both control subject and patient PBMCs. Patient PBMCs failed to recognize Leptospira protein antigens. Leptospirosis does not seem to generate memory T cells that can be activated by in vitro stimulation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20053135      PMCID: PMC2877911          DOI: 10.1086/650300

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

Review 1.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Peripheral blood mononuclear cell activation induced by Leptospira interrogans glycolipoprotein.

Authors:  Decio Diament; Milena Karina Colo Brunialti; Eliete Calo Romero; Esper Georges Kallas; Reinaldo Salomao
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection.

Authors:  D A Haake; M K Mazel; A M McCoy; F Milward; G Chao; J Matsunaga; E A Wagar
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

4.  Asymptomatic infection and risk factors for leptospirosis in Nicaragua.

Authors:  D A Ashford; R M Kaiser; R A Spiegel; B A Perkins; R S Weyant; S L Bragg; B Plikaytis; C Jarquin; J O De Lose Reyes; J J Amador
Journal:  Am J Trop Med Hyg       Date:  2000 Nov-Dec       Impact factor: 2.345

5.  Evidence of cross-protection within Leptospira interrogans in an experimental model.

Authors:  C Sonrier; C Branger; V Michel; N Ruvoën-Clouet; J P Ganière; G André-Fontaine
Journal:  Vaccine       Date:  2000-08-15       Impact factor: 3.641

6.  The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection.

Authors:  D A Haake; G Chao; R L Zuerner; J K Barnett; D Barnett; M Mazel; J Matsunaga; P N Levett; C A Bolin
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 7.  Leptospirosis.

Authors:  J M Vinetz
Journal:  Curr Opin Infect Dis       Date:  2001-10       Impact factor: 4.915

8.  Protective killed Leptospira borgpetersenii vaccine induces potent Th1 immunity comprising responses by CD4 and gammadelta T lymphocytes.

Authors:  B M Naiman; D Alt; C A Bolin; R Zuerner; C L Baldwin
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

9.  Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis.

Authors:  Paul N Levett
Journal:  Clin Infect Dis       Date:  2003-01-29       Impact factor: 9.079

10.  Phenotypic and functional characterization of human memory T cell responses to Burkholderia pseudomallei.

Authors:  Patcharaporn Tippayawat; Wipawee Saenwongsa; Jirawan Mahawantung; Duangchan Suwannasaen; Ploenchan Chetchotisakd; Direk Limmathurotsakul; Sharon J Peacock; Philip L Felgner; Helen S Atkins; Richard W Titball; Gregory J Bancroft; Ganjana Lertmemongkolchai
Journal:  PLoS Negl Trop Dis       Date:  2009-04-07
View more
  7 in total

1.  Severe Leptospirosis Features in the Spleen Indicate Cellular Immunosuppression Similar to That Found in Septic Shock.

Authors:  Amaro Nunes Duarte-Neto; Julio Croda; Carla Pagliari; Francisco Garcia Soriano; Antonio Carlos Nicodemo; Maria Irma Seixas Duarte
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

2.  Biannual and Quarterly Comparison Analysis of Agglutinating Antibody Kinetics on a Subcohort of Individuals Exposed to Leptospira interrogans in Salvador, Brazil.

Authors:  Jaqueline S Cruz; Nivison Nery; Gielson A Sacramento; Renato Victoriano; Albino L S Montenegro; Juliet O Santana; Federico Costa; Albert I Ko; Mitermayer G Reis; Elsio A Wunder
Journal:  Front Med (Lausanne)       Date:  2022-04-14

3.  Pathogenic Leptospires Limit Dendritic Cell Activation Through Avoidance of TLR4 and TRIF Signaling.

Authors:  Julie Cagliero; Frédérique Vernel-Pauillac; Gerald Murray; Ben Adler; Mariko Matsui; Catherine Werts
Journal:  Front Immunol       Date:  2022-06-22       Impact factor: 8.786

4.  Leptospira and inflammation.

Authors:  C F Gonçalves-de-Albuquerque; P Burth; A R Silva; M Younes-Ibrahim; H C Castro-Faria-Neto; M V Castro-Faria
Journal:  Mediators Inflamm       Date:  2012-10-21       Impact factor: 4.711

5.  Estimating leptospirosis incidence using hospital-based surveillance and a population-based health care utilization survey in Tanzania.

Authors:  Holly M Biggs; Julian T Hertz; O Michael Munishi; Renee L Galloway; Florian Marks; Wilbrod Saganda; Venance P Maro; John A Crump
Journal:  PLoS Negl Trop Dis       Date:  2013-12-05

6.  Cytokine response in human leptospirosis with different clinical outcomes: a systematic review.

Authors:  Indika Senavirathna; Devarajan Rathish; Suneth Agampodi
Journal:  BMC Infect Dis       Date:  2020-04-07       Impact factor: 3.090

7.  Association Between Severity of Leptospirosis and Subsequent Major Autoimmune Diseases: A Nationwide Observational Cohort Study.

Authors:  Chih-Chung Chen; Yao-Min Hung; Lu-Ting Chiu; Mei-Chia Chou; Renin Chang; James Cheng-Chung Wei
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.